SCHEMBL19484192

SCHEMBL19484192

CCN(C)C(C)(C)CCNC(=O)c1cc(OC)on1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
NPC1 O15118 4/20 0.42
TP53 P04637 4/20 0.42
ALDH1A1 P00352 6/20 0.41
HPGD P15428 7/20 0.41
HSD17B10 Q99714 3/20 0.41
CYP1A2 P05177 2/20 0.41
KDM4E B2RXH2 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPT P10636 4/20 0.39
LMNA P02545 4/20 0.39
GAA P10253 1/20 0.39
THRB P10828 1/20 0.39
HDAC3 O15379 2/20 0.38
HDAC4 P56524 2/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC7 Q8WUI4 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC10 Q969S8 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19484190 0.89 RAB9A (0.44) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19484164 0.88 SLC6A5 (0.41) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19484189 0.83 RAB9A (0.46) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19484059 0.83 THRB (0.48) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19484166 0.81 HPGD (0.38) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19484204 0.80 RAB9A (0.45) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19484186 0.80 RAB9A (0.45) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19484201 0.79 RAB9A (0.48) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19484165 0.79 SLC6A5 (0.46) RAB9ASMN1; SMN2NPC1TP53ALDH1A1
SCHEMBL19484202 0.78 CYP2D6 (0.47) RAB9ASMN1; SMN2NPC1TP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170295789-A1 AMIDE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170295789-A1 AMIDE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL OPRM1, TRPA1, L3MBTL3 RAB9A 753/4885SMN1; SMN2 1274/4885NPC1 3696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.